NCT03988166 - Chronic Total Occlusion Percutaneous Coronary Intervention Study | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

February 22, 2021

Study Completion Date

February 22, 2021

Conditions

Chronic Total OcclusionIschemic Heart DiseaseChronic Total Occlusion of Coronary Artery

Interventions

PROCEDURE

Chronic Total Occlusion Revascularization

Teleflex's series of study guidewires and catheters will be used to facilitate the safe and effective crossing of de novo CTOs and placement of conventional guidewires beyond the lesion via either a true lumen or subintimal pathway.

DEVICE

GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter

Trial Locations (13)

10016

NYU Langone Health, New York

10032

Columbia University Medical Center, New York

30309

Piedmont Heart Institute, Atlanta

30322

Emory University, Atlanta

45219

The Christ Hospital, Cincinnati

48202

Henry Ford Hospital, Detroit

55407

Minneapolis Heart Institute Foundation, Minneapolis

65201

Missouri Cardiovascular Specialists, Columbia

90505

Torrance Memorial Medical Center, Torrance

98195

University of Washington, Seattle

02115

Brigham and Women's Hospital, Boston

02214

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

collaborator

Teleflex

INDUSTRY

collaborator

Bright Research Partners

INDUSTRY

lead

Vascular Solutions LLC

INDUSTRY